Key result
Supratherapeutic lithium is linked to a ~7-fold higher rate of prolonged QTc.
Why the study?
The correlation between serum lithium levels and electrocardiographic changes has never been characterized in a systematic way.
Do ECG abnormalities (QTc >440 ms and diffuse T wave inversion) predict over-range lithium levels in patients undergoing lithium treatment?
Observational (n=76)
Do ECG abnormalities (QTc >440 ms and diffuse T wave inversion) predict over-range lithium levels in patients undergoing lithium treatment?
QTc interval >440 ms and diffuse T wave inversion are highly specific predictors of over-range lithium levels, suggesting routine ECG monitoring could aid in early detection of lithium toxicity.
Answers are grounded in this paper and cite their sources.
Retrospective lithium-ECG correlations warrant cautious interpretation; leaves open prospective confirmation of clinical relevance.
BACKGROUND: Lithium compounds have been widely used in the treatment of manic-depressive illness. Several electrocardiogram (ECG) abnormalities, including ventricular arrhythmias, atrioventricular conduction abnormalities, T wave changes and QT interval prolongation, have been reported to be associated with lithium. However, the correlation between serum lithium levels and ECG changes has never been characterized in a systematic way. METHODS: This retrospective study included 76 patients undergoing lithium treatment with available records of lithium levels. Eleven patients (4 men) had serum lithium levels >1.2 mEq/l and were diagnosed as lithium over range. Clinical characteristics and various ECG changes were analyzed in patients with and without lithium over range. RESULTS: Patients with lithium over range had a slower heart rate and longer PR, QT and corrected QT (QTc) intervals. QTc interval >440 ms was more commonly found in patients with lithium over range (55 vs. 8%, p < 0.001). Similarly, diffuse T wave inversion was more commonly associated with lithium over range (73 vs. 17%, p < 0.001). The daily dosage of lithium was similar between patients with and without over-range lithium levels. When these two ECG changes were combined, the sensitivity and specificity in predicting lithium over range were 64 and 97%, respectively. These findings were independent of the concomitant use of beta-blockers. CONCLUSIONS: QTc interval >440 ms and diffuse T wave inversion were significantly more common in patients with lithium over range, and were good predictors of lithium over range. More liberal checkup of the ECG in patients undergoing lithium treatment may be of help in the early detection of lithium over range.
No takes yet. Share an insight, caveat, or question.
Hsu et al. (2004) conducted an observational in Manic-depressive illness on lithium treatment (n=76). Lithium over range (>1.2 mEq/l) vs. Lithium levels within range was evaluated on QTc interval >440 ms (p=<0.001). Lithium over range was associated with a higher prevalence of QTc interval >440 ms and diffuse T wave inversion.
Synapse has enriched 10 related papers. Consider them for comparative context: